For more than a decade, Lynnette lived in the shadow of debilitating pain. What began as persistent discomfort in her back ...

On Saturday, Oct. 11, HSHS St. Elizabeth’s Hospital will host a free educational seminar to raise awareness of the benefit ...

Personalized, at-home, adaptive deep brain stimulation is safe and effective for patients with moderate-to-advanced Parkinson ...

Recently FDA-cleared, adaptive deep brain stimulation is gaining global traction, offering real-time, personalized therapy ...

Brett Wall has overseen the neuroscience portfolio of Medtronic, one of the world’s largest medical device makers valued at ...

Medtronic (NYSE: MDT) today announced study results backing its adaptive DBS algorithm for personalized therapy in ...

The global Neuromodulation Market , valued at US$6.26 billion in 2024, stood at US$6.81 billion in 2025 and is projected to ...

Nearly 50 new cancer therapies are approved every year. This is good news. "But for patients and their treating physicians, it is becoming increasingly difficult to keep track and to select the ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...

WEDNESDAY, Sept. 3, 2025 (HealthDay News) -- Obtaining a prefrontal cortex (PFC) biopsy during deep brain stimulation (DBS) procedures is safe, according to a study published online Sept. 3 in ...

Medtronic plc (NYSE:MDT) is one of the top stock picks in Ken Griffin’s portfolio. On August 25, analysts at TD Cowen reiterated a ‘Buy’ rating on the stock and a $106 price target. The bullish stance ...

Psychotherapy leads to measurable changes in brain structure. Researchers at Martin Luther University Halle-Wittenberg (MLU) and the University of Münster have demonstrated this for the first time in ...